Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Women news

Show

From To
What triggered my heart attack?

Jackie Morton, ex-Chair of the European AIDS Treatment Group, found her severe pain was due to a heart attack. Here she writes a detailed, dispassionate and scientific blog on the possible causes - and remedies.

Published
19 November 2018
From
EATG
HIV rates lower in states that target intimate partner violence

States that aggressively target intimate partner violence (IPV) in their health care systems have lower rates of HIV infection among women, according to a new study led by researchers at the Yale School of Public Health. The findings reinforce the belief that exposure to intimate partner violence increases a woman’s risk for HIV infection and suggest that integrating comprehensive IPV policies at the state level can positively impact women’s health. TIARA WILLIE The study appears in the journal Annals of Epidemiology.

Published
16 November 2018
From
Yale News
HIV Risk Greatest During Follicular Phase of Menstrual Cycle

The follicular phase of the menstrual cycle may be the most vulnerable time for HIV-1 acquisition in women—not the luteal phase, as previously thought—according to the results of a new study published online October 31 in The Journal of Infectious Diseases.

Published
16 November 2018
From
Contagionlive.com
FGM rates in east Africa drop from 71% to 8% in 20 years, study shows

Analysis in BMJ Global Health suggests dramatic decline in number of girls undergoing the practice, yet experts advise caution over the figures

Published
08 November 2018
From
The Guardian
Los Angeles PrEP outreach campaign targets at-risk women

The Los Angeles County Department of Public Health has created a series of videos to raise awareness among women about Pre-Exposure Prophylaxis as part of a campaign called GetPrEP LA.

Published
05 November 2018
From
Daily Bulletin
PrEP Is Safe for Pregnant Women Who Want the HIV Prevention Drug, a New Study Finds

Pre-exposure prophylaxis, or PrEP, is safe for pregnant women to use, according to new research presented at the HIV Research for Prevention (HIVR4P2018) conference in Madrid, Spain.

Published
05 November 2018
From
The Body Pro
Reaching the men: who are the partners of the young women with HIV in South Africa?

In the high-prevalence countries of southern Africa, young women under 25 bear the brunt of the epidemic, with continued high rates of HIV infection. So

Published
05 November 2018
By
Gus Cairns
Going local – prevention conference hears about rings, douches, and soluble suppositories

Last week’s HIV Research for Prevention conference (HIVR4P 2018) in Madrid heard a lot about oral pre-exposure prophylaxis (PrEP): not only its efficacy but also

Published
31 October 2018
By
Gus Cairns
Vaginal rings, films, inserts or gels – it’s all about choice

There is no single HIV prevention technology which suits everyone – young African women who have tried four different vaginal products make different choices, with no one

Published
26 October 2018
By
Roger Pebody
Young women, their male partners and HIV – how relationships vary across settings

New research comparing partners of adolescent girls and young women in Kenya and South Africa reveals important differences between settings – giving further evidence for the need to contextualise HIV responses.

Published
23 October 2018
From
AVERT
← First12345...64Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.